FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2313893287> ?p ?o ?g. }

• W2313893287 endingPage "31" @default.
• W2313893287 startingPage "25" @default.
• W2313893287 abstract "The morphologic distinction of ependymomas with epithelial cytology from metastatic carcinoma may pose a significant problem in differential diagnosis. The known presence of keratin in glioma cells further complicates the issue. Using the labeled streptavidin-biotin method with automated staining, we studied epithelial and glial marker expression in 52 ependymomas of varying type and grade, including 20 epithelial-appearing, 14 glial-appearing, eight mixed pattern, and 10 myxopapillary tumors; 38 were low grade and 14 anaplastic. All tumors were immunoreactive for glial fibrillary acidic protein (GFAP), and S-100 protein. Diffuse staining for GFAP was noted in glial-appearing ependymomas featuring perivascular pseudorosettes. Diffuse immunostaining for S-100 protein was seen in cellular lesions exhibiting epithelial-like features. Staining was more diffuse for GFAP than S-100 protein in anaplastic ependymomas. Keratin (AE1/AE3) reactivity was seen in 98% of cases, the pattern being similar to that of GFAP. The frequency of staining for other keratins varied: wide-spectrum keratin (35%), cytokeratin (CK)7 (20%), CAM 5.2 (19%), CK903 (14%), and CK20 (8%); as a rule, it was scant and limited to occasional cells and processes. epithelial membrane antigen (EMA) staining was seen in 36% of all cases and in 67% of epithelial-appearing tumors wherein it often highlighted microlumina. Aside from AE1/AE3 staining and very infrequent wide-spectrum keratin and EMA reactivity, expression of epithelial markers was not seen in anaplastic ependymomas. No carcinoembryonic antigen (CEA) positivity was noted in any case. Collagen IV reactivity was limited to tumor cell–stroma interfaces. Although variable, S-100 protein and GFAP staining is seen in all ependymomas, particularly in true and perivascular pseudorosettes. Widespread reactivity for keratin AE1/AE3 corresponds closely to the pattern of GFAP staining. Significant staining for other keratins or for CEA is inconsistent with a diagnosis of ependymoma. EMA reactivity is largely limited to luminal staining of rosettes and tubules." @default.
• W2313893287 created "2016-06-24" @default.
• W2313893287 creator A5003415862 @default.
• W2313893287 creator A5049749614 @default.
• W2313893287 creator A5069689120 @default.
• W2313893287 date "2000-03-01" @default.
• W2313893287 modified "2023-10-11" @default.
• W2313893287 title "The Immunophenotype of Ependymomas" @default.
• W2313893287 cites W163592829 @default.
• W2313893287 cites W1964067120 @default.
• W2313893287 cites W1966010417 @default.
• W2313893287 cites W1968385815 @default.
• W2313893287 cites W2005048186 @default.
• W2313893287 cites W2006924263 @default.
• W2313893287 cites W2009239522 @default.
• W2313893287 cites W2009806 @default.
• W2313893287 cites W2009880872 @default.
• W2313893287 cites W2015599292 @default.
• W2313893287 cites W2016693266 @default.
• W2313893287 cites W2021898585 @default.
• W2313893287 cites W2026812469 @default.
• W2313893287 cites W2029182205 @default.
• W2313893287 cites W2038775146 @default.
• W2313893287 cites W2039113456 @default.
• W2313893287 cites W2040651131 @default.
• W2313893287 cites W2046323887 @default.
• W2313893287 cites W2062820853 @default.
• W2313893287 cites W2064828508 @default.
• W2313893287 cites W2069141871 @default.
• W2313893287 cites W2079281464 @default.
• W2313893287 cites W2080370755 @default.
• W2313893287 cites W2082956698 @default.
• W2313893287 cites W2085168665 @default.
• W2313893287 cites W2088201430 @default.
• W2313893287 cites W2088209159 @default.
• W2313893287 cites W2090526822 @default.
• W2313893287 cites W2091722511 @default.
• W2313893287 cites W2111865039 @default.
• W2313893287 cites W2137541387 @default.
• W2313893287 cites W2139838398 @default.
• W2313893287 cites W2161788661 @default.
• W2313893287 cites W2169798285 @default.
• W2313893287 cites W2885893637 @default.
• W2313893287 cites W4244241138 @default.
• W2313893287 cites W4372141623 @default.
• W2313893287 doi "https://doi.org/10.1097/00129039-200003000-00004" @default.
• W2313893287 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10937045" @default.
• W2313893287 hasPublicationYear "2000" @default.
• W2313893287 type Work @default.
• W2313893287 sameAs 2313893287 @default.
• W2313893287 citedByCount "37" @default.
• W2313893287 countsByYear W23138932872012 @default.
• W2313893287 countsByYear W23138932872013 @default.
• W2313893287 countsByYear W23138932872015 @default.
• W2313893287 countsByYear W23138932872017 @default.
• W2313893287 countsByYear W23138932872018 @default.
• W2313893287 countsByYear W23138932872019 @default.
• W2313893287 countsByYear W23138932872021 @default.
• W2313893287 countsByYear W23138932872022 @default.
• W2313893287 countsByYear W23138932872023 @default.
• W2313893287 crossrefType "journal-article" @default.
• W2313893287 hasAuthorship W2313893287A5003415862 @default.
• W2313893287 hasAuthorship W2313893287A5049749614 @default.
• W2313893287 hasAuthorship W2313893287A5069689120 @default.
• W2313893287 hasConcept C121608353 @default.
• W2313893287 hasConcept C142724271 @default.
• W2313893287 hasConcept C147447768 @default.
• W2313893287 hasConcept C189689871 @default.
• W2313893287 hasConcept C204232928 @default.
• W2313893287 hasConcept C2777387746 @default.
• W2313893287 hasConcept C2779012181 @default.
• W2313893287 hasConcept C2780495277 @default.
• W2313893287 hasConcept C2781432949 @default.
• W2313893287 hasConcept C4224716 @default.
• W2313893287 hasConcept C54355233 @default.
• W2313893287 hasConcept C71924100 @default.
• W2313893287 hasConcept C74864618 @default.
• W2313893287 hasConcept C81241287 @default.
• W2313893287 hasConcept C86803240 @default.
• W2313893287 hasConceptScore W2313893287C121608353 @default.
• W2313893287 hasConceptScore W2313893287C142724271 @default.
• W2313893287 hasConceptScore W2313893287C147447768 @default.
• W2313893287 hasConceptScore W2313893287C189689871 @default.
• W2313893287 hasConceptScore W2313893287C204232928 @default.
• W2313893287 hasConceptScore W2313893287C2777387746 @default.
• W2313893287 hasConceptScore W2313893287C2779012181 @default.
• W2313893287 hasConceptScore W2313893287C2780495277 @default.
• W2313893287 hasConceptScore W2313893287C2781432949 @default.
• W2313893287 hasConceptScore W2313893287C4224716 @default.
• W2313893287 hasConceptScore W2313893287C54355233 @default.
• W2313893287 hasConceptScore W2313893287C71924100 @default.
• W2313893287 hasConceptScore W2313893287C74864618 @default.
• W2313893287 hasConceptScore W2313893287C81241287 @default.
• W2313893287 hasConceptScore W2313893287C86803240 @default.
• W2313893287 hasIssue "1" @default.
• W2313893287 hasLocation W23138932871 @default.
• W2313893287 hasLocation W23138932872 @default.
• W2313893287 hasOpenAccess W2313893287 @default.

• next